Drugs / LHF-535
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT03993704 | Sep 2019 → Jan 2020 | — | Kineta Inc. | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | LHF-535 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03993704 ↗ |
| Modality | Small molecule | — CHEMBL4537239 ↗ |
| Route | Oral | “orally administered LHF-535” NCT03993704 ↗ |